FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286296876> ?p ?o ?g. }

• W4286296876 endingPage "e18815" @default.
• W4286296876 startingPage "e18815" @default.
• W4286296876 abstract "e18815 Background: Disparities in diagnosis, treatment, and outcomes for bladder cancer in underserved patient populations persist in the United States. High out-of-pocket costs can prevent patients from seeking or continuing treatment, which can worsen existing disparities in care. The Association of Community Cancer Centers (ACCC) conducted a claims analysis of Medicare beneficiaries diagnosed with bladder cancer to assess differences in healthcare utilization and costs and to inform future provider education initiatives. Methods: ACCC convened an expert steering committee of multidisciplinary specialists and patient advocates to guide the development of the claims analysis methodology and code sets used to identify study cohorts and model variables. Using the CMS Medicare 100% Innovator Administrative Claims Data Set, incident patients were defined as those newly diagnosed in 2018 using a 24-month lookback to confirm no prior bladder cancer diagnosis. Claims for incident patients incurred in the time-period between 24 months prior to and 24 months following diagnosis date were analyzed to generate descriptive summaries of cohorts by severity of disease at diagnosis. Classification is defined by treatment observed within 6 months of diagnosis: No treatment, Early Stage-treated (intravesical chemotherapy), and Late-stage (one or more claims of non-intravesical systemic therapy, radiation therapy, or major bladder surgery). Results: 4,356 incident patients were identified: average age 77.7, 71% male, 56% no treatment, 15% early-stage treated, 28% late-stage. Patients diagnosed at late-stage incur 128% more allowed costs (total amount paid by Medicare and patients) on all-cause healthcare in the first year after diagnosis than early-stage patients who receive treatment ($76,483 vs $33,530) and 101% higher cumulative costs two years following diagnosis ($112,178 vs $55,814). Patients diagnosed at late-stage incur 90% more out-of-pocket costs (copays, coinsurance, deductibles) in the first year following diagnosis than early-stage treated patients ($9,970 vs $5,225) and 81% higher cumulative out-of-pocket costs two years following diagnosis ($15,145 vs $8,390). For both early- and late-stage patients, the month of diagnosis is the most expensive. 53% of all costs incurred in the month of diagnosis are for cystoscopy/TURBT procedures. Elevated costs persist at levels higher than pre-diagnosis levels for at least 20 months. Among late-stage patients, treatments (surgery, radiation therapy, and systemic therapy) sum to 34% of all costs incurred in 6 months following diagnosis. Conclusions: Patients diagnosed with late-stage bladder cancer experience higher financial burden and need more resource-intensive services than those diagnosed at an earlier stage. Earlier diagnosis of bladder cancer is needed to improve patient outcomes and reduce financial burden." @default.
• W4286296876 created "2022-07-21" @default.
• W4286296876 creator A5000395283 @default.
• W4286296876 creator A5003853320 @default.
• W4286296876 creator A5011367118 @default.
• W4286296876 creator A5018572445 @default.
• W4286296876 creator A5035665916 @default.
• W4286296876 creator A5062997939 @default.
• W4286296876 creator A5075348201 @default.
• W4286296876 creator A5090727184 @default.
• W4286296876 date "2022-06-01" @default.
• W4286296876 modified "2023-09-27" @default.
• W4286296876 title "Using real-world data to assess variations in cost and healthcare utilization for patients diagnosed with bladder cancer." @default.
• W4286296876 doi "https://doi.org/10.1200/jco.2022.40.16_suppl.e18815" @default.
• W4286296876 hasPublicationYear "2022" @default.
• W4286296876 type Work @default.
• W4286296876 citedByCount "0" @default.
• W4286296876 crossrefType "journal-article" @default.
• W4286296876 hasAuthorship W4286296876A5000395283 @default.
• W4286296876 hasAuthorship W4286296876A5003853320 @default.
• W4286296876 hasAuthorship W4286296876A5011367118 @default.
• W4286296876 hasAuthorship W4286296876A5018572445 @default.
• W4286296876 hasAuthorship W4286296876A5035665916 @default.
• W4286296876 hasAuthorship W4286296876A5062997939 @default.
• W4286296876 hasAuthorship W4286296876A5075348201 @default.
• W4286296876 hasAuthorship W4286296876A5090727184 @default.
• W4286296876 hasConcept C121608353 @default.
• W4286296876 hasConcept C126322002 @default.
• W4286296876 hasConcept C146357865 @default.
• W4286296876 hasConcept C151730666 @default.
• W4286296876 hasConcept C160735492 @default.
• W4286296876 hasConcept C162324750 @default.
• W4286296876 hasConcept C177713679 @default.
• W4286296876 hasConcept C194828623 @default.
• W4286296876 hasConcept C2778527826 @default.
• W4286296876 hasConcept C2779134260 @default.
• W4286296876 hasConcept C2780352672 @default.
• W4286296876 hasConcept C50522688 @default.
• W4286296876 hasConcept C512399662 @default.
• W4286296876 hasConcept C71924100 @default.
• W4286296876 hasConcept C86803240 @default.
• W4286296876 hasConceptScore W4286296876C121608353 @default.
• W4286296876 hasConceptScore W4286296876C126322002 @default.
• W4286296876 hasConceptScore W4286296876C146357865 @default.
• W4286296876 hasConceptScore W4286296876C151730666 @default.
• W4286296876 hasConceptScore W4286296876C160735492 @default.
• W4286296876 hasConceptScore W4286296876C162324750 @default.
• W4286296876 hasConceptScore W4286296876C177713679 @default.
• W4286296876 hasConceptScore W4286296876C194828623 @default.
• W4286296876 hasConceptScore W4286296876C2778527826 @default.
• W4286296876 hasConceptScore W4286296876C2779134260 @default.
• W4286296876 hasConceptScore W4286296876C2780352672 @default.
• W4286296876 hasConceptScore W4286296876C50522688 @default.
• W4286296876 hasConceptScore W4286296876C512399662 @default.
• W4286296876 hasConceptScore W4286296876C71924100 @default.
• W4286296876 hasConceptScore W4286296876C86803240 @default.
• W4286296876 hasIssue "16_suppl" @default.
• W4286296876 hasLocation W42862968761 @default.
• W4286296876 hasOpenAccess W4286296876 @default.
• W4286296876 hasPrimaryLocation W42862968761 @default.
• W4286296876 hasRelatedWork W1979321249 @default.
• W4286296876 hasRelatedWork W2002775905 @default.
• W4286296876 hasRelatedWork W2011500441 @default.
• W4286296876 hasRelatedWork W2144610094 @default.
• W4286296876 hasRelatedWork W2356105190 @default.
• W4286296876 hasRelatedWork W2474195589 @default.
• W4286296876 hasRelatedWork W2589770771 @default.
• W4286296876 hasRelatedWork W2945937321 @default.
• W4286296876 hasRelatedWork W3199774226 @default.
• W4286296876 hasRelatedWork W2118673085 @default.
• W4286296876 hasVolume "40" @default.
• W4286296876 isParatext "false" @default.
• W4286296876 isRetracted "false" @default.
• W4286296876 workType "article" @default.